Skip to main content

Farzan, Michael R.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #593
  • Rising Star
  • Sustained Excellence
  • Top 5% Funded
  • R01 Holder
  • Long-Funded
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Pathology

NIH Funding · FY2023

Linked Award Amount
$5.7M
Full award amounts, FY2023
Award Records
8
Records listing this PI
Award-Linked Rank
#593
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Farzan, Michael R.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Farzan, Michael R. as a PI. Multi-PI records show the full award amount for context.

  • 7U19AI149646-04U19Contact PI
    An AAV-mediated functional cure and its impact on the reservoir
    $2.6M
    award amount
  • 1R01NS131098-01A1R01Contact PI
    eCD4-mediated control of SIV infection in the brain
    $914.1K
    award amount
  • 7R01DA056771-02R01Contact PI
    Engineering CAR-B cells for an HIV-1 functional cure
    $741.1K
    award amount
  • 5R37AI091476-14R37Contact PI
    Therapeutic Use of an Enhanced Form of CD4-Ig
    University of Florida · Pathology (NIH department code)
    $721.7K
    award amount
  • 1R21AI178031-01R21Contact PI
    Safe, CRISPR/Cas-free B cell editing for therapeutic applications
    $221.3K
    award amount
  • 7R37AI091476-15R37Contact PI
    Therapeutic use of an enhanced form of CD4-Ig
    $200.1K
    award amount
  • 7R21AI173596-02R21Contact PI
    Improving mRNA vaccines with extracellular vesicle-associated immunogens
    $189.6K
    award amount
  • 1R21AI173596-01R21Contact PI
    Improving mRNA vaccines with extracellular vesicle-associated immunogens
    University of Florida · Pathology (NIH department code)
    $82.8K
    award amount

Award organizations

Organizations that administered FY2023 awards listing Farzan, Michael R. as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Boston Children's Hospital
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #6156
  4. 2007
    $1M Cumulative Funding
  5. 2007
    $2M Cumulative Funding
  6. 2007
    Entered Top 25% Nationally
    Ranked #4173
  7. 2007
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2011
    $5M Cumulative Funding
  9. 2012
    Entered Top 10% Nationally
    Ranked #1166
  10. 2012
    R01 Grant Holder
  11. 2013
    $10M Cumulative Funding
  12. 2013
    Entered Top 5% Nationally
    Ranked #947
  13. 2017
    $25M Cumulative Funding
  14. 2020
    Entered Top 1% Nationally
    Ranked #184
  15. 2023
    $50M Cumulative Funding